相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relaxation effect of a novel Danshensu/tetramethylpyrazine derivative on rat mesenteric arteries
Rachel Wai-Sum Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy
Guozhen Cui et al.
SCIENTIFIC REPORTS (2015)
Identification of disulfide isomerase ERp57 as a target for small molecule cardioprotective agents
Guozhen Cui et al.
RSC ADVANCES (2015)
Therapeutic Effects of Multifunctional Tetramethylpyrazine Nitrone on Models of Parkinson's Disease in Vitro and in Vivo
Baojian Guo et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Design, Synthesis, and Preliminary Cardioprotective Effect Evaluation of Danshensu Derivatives
Qingbin Cui et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2014)
Neuroprotective Effects of Tetramethylpyrazine against Dopaminergic Neuron Injury in a Rat Model of Parkinson's Disease Induced by MPTP
Chen Lu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
The Novel Tetramethylpyrazine Bis-nitrone (TN-2) Protects Against MPTP/MPP+-Induced Neurotoxicity via Inhibition of Mitochondrial-Dependent Apoptosis
Daping Xu et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2014)
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
Jeffrey Cummings et al.
LANCET (2014)
A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-κB and the PKCα/PI3-K/Akt pathways
Da-Ping Xu et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Discovery of a Natural Product-Like iNOS Inhibitor by Molecular Docking with Potential Neuroprotective Effects In Vivo
Hai-Jing Zhong et al.
PLOS ONE (2014)
A novel Danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways
Guozhen Cui et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish
Cheong-Meng Chong et al.
NEUROSCIENCE LETTERS (2013)
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Lars Brichta et al.
TRENDS IN NEUROSCIENCES (2013)
Ethanolic Extract of Fructus Alpinia oxyphylla Protects Against 6-Hydroxydopamine-Induced Damage of PC12 Cells In Vitro and Dopaminergic Neurons in Zebrafish
Zai-Jun Zhang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Bis(12)-hupyridone, a novel multifunctional dimer, promotes neuronal differentiation more potently than its monomeric natural analog huperzine A possibly through alpha7 nAChR
Wei Cui et al.
BRAIN RESEARCH (2011)
Increased expression of neutrophil gelatinase-associated lipocalin receptor by interleukin-1β in human mesangial cells via MAPK/ERK activation
Shanshan Mao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
Eriocaulon buergerianum extract protects PC12 cells and neurons in zebrafish against 6-hydroxydopamine-induced damage
Meiwei Wang et al.
CHINESE MEDICINE (2011)
Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Joern R. Steinert et al.
NEUROSCIENTIST (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Oxidative Stress in Parkinson's Disease A Mechanism of Pathogenic and Therapeutic Significance
Chun Zhou et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
A zebrafish assay for identifying neuroprotectants in vivo
Chuenlei Parng et al.
NEUROTOXICOLOGY AND TERATOLOGY (2006)
In vivo drug discovery in the zebrafish
LI Zon et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design
R Fedorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Subcutaneous apomorphine - An evidence-based review of its use in Parkinson's disease
D Deleu et al.
DRUGS & AGING (2004)
分享论文
